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Abstract
The immune mechanisms which determine the infection duration induced by pathogens targeting pulmonary
macrophages are poorly known. To explore the impact of such pathogens, it is indispensable to integrate the various
immune mechanisms and to take into account the variability in pathogen virulence and host susceptibility. In this context,
mathematical models complement experimentation and are powerful tools to represent and explore the complex
mechanisms involved in the infection and immune dynamics. We developed an original mathematical model in which we
detailed the interactions between the macrophages and the pathogen, the orientation of the adaptive response and the
cytokine regulations. We applied our model to the Porcine Respiratory and Reproductive Syndrome virus (PRRSv), a major
concern for the swine industry. We extracted value ranges for the model parameters from modelling and experimental
studies on respiratory pathogens. We identified the most influential parameters through a sensitivity analysis. We defined a
parameter set, the reference scenario, resulting in a realistic and representative immune response to PRRSv infection. We
then defined scenarios corresponding to graduated levels of strain virulence and host susceptibility around the reference
scenario. We observed that high levels of antiviral cytokines and a dominant cellular response were associated with either
short, the usual assumption, or long infection durations, depending on the immune mechanisms involved. To identify these
mechanisms, we need to combine the levels of antiviral cytokines, including IFNc, and IL10. The latter is a good indicator of
the infected macrophage level, both combined provide the adaptive response orientation. Available PRRSv vaccines lack
efficiency. By integrating the main interactions between the complex immune mechanisms, this modelling framework could
be used to help designing more efficient vaccination strategies.
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Introduction
Respiratory pathogens, which enter the body through the
mucosal surfaces of the respiratory tract, are responsible for local
inflammation and tissue damages [1,2]. They initiate the infection
and the immune response. The first interaction between the
pathogen and the immune system involves the innate immune
system. This first line of defence, which includes epithelial surfaces,
inflammation process, complement system and innate cells,
provides an immediate but non-specific response. The innate
cells mainly consist of the pulmonary macrophages, the dendritic
cells and the natural killers. Macrophages and dendritic cells
phagocyte the pathogens, whereas the natural killers destroy the
host infected cells. If pathogens successfully evade the innate
response, a second layer of protection is provided by the adaptive
immune system, which is activated by the innate response and
confers specific long-lasting protective immunity to the host. The
adaptive immune system mainly involves the cellular, the humoral
and the regulatory responses. The cellular effectors destroy the
infected cells, whereas the humoral effectors release antibodies,
which are responsible for the neutralisation of free viral particles.
The regulatory response mainly inhibits the adaptive response.
Innate and adaptive immune cells synthesise cytokines, small
proteins which regulate the immune mechanisms in complex ways.
The best strategy to control the severity of respiratory pathogens
is to limit the inflammation while maintaining an efficient immune
response. Some pathogens, such as influenza viruses, Mycobacte-
rium tuberculosis or the Porcine Reproductive and Respiratory
Syndrome virus, replicate in the cells of the respiratory tract,
including pulmonary macrophages. They hinder the immune
functions of the macrophages and consequently reduce the efficacy
of the immune response. With these pathogens, activated
macrophages (i) either phagocyte and destroy the pathogen, or
are infected and excrete the pathogen; (ii) produce cytokines that
promote the migration of immune cells to the infection site; (iii)
synthesise cytokines that regulate the adaptive immunity; (iv)
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express antigen proteins on their cell surface that activate the adaptive
response. In turn, the adaptive cell effectors and cytokines regulate
the immune functions of macrophages. However, the influence of
macrophage–pathogen interactions on the immune response has
been poorly studied and needs more insight [1–4]. The two major
reasons are that the innate mechanisms are very difficult to explore by
experimentation in vivo and that they have been considered as
having little impact compared to the adaptive response.
Here, we were interested in identifying the immune mechanisms
which determine the infection duration induced by pathogens
targeting pulmonary macrophages. The immune response is a highly
complex system involving numerous interactions between cells and
cytokines. An additional level of complexity is due to the between-
host and between-pathogen variability. Pathogens use multiple
strategies, that vary among pathogens but also among strains,
resulting in various virulence levels. The host response depends on the
host genotype or housing conditions, resulting in various susceptibility
levels to a given pathogen. Consequently, to explore the impact of
pathogens targeting pulmonary macrophages, it is indispensable to
integrate the various immune mechanisms and to take into account
the variability in pathogen virulence and host susceptibility.
In this context, mathematical models are powerful tools to
represent and explore the complex mechanisms involved in the
infection and immune dynamics [3,5]. They complement exper-
imentation. On the one hand, they are based on experimental
data. On the other hand, they can be used to test biological
hypotheses or assess the impact of control strategies, which would
not be feasible or would be too expensive by experimentation.
They can also guide experimentation by identifying key param-
eters or mechanisms that need further exploration. Mathematical
models have been developed to explore the immune and infection
dynamics for various human and animal diseases. However, very
few models represent the innate mechanisms explicitly and
macrophage–pathogen interactions need to be better represented
in models [6]. Several models describe pathogens targeting
macrophages, such as influenza viruses [5–7], Mycobacterium
tuberculosis [8,9], or Porcine Respiratory and Reproductive
Syndrome virus [10]. These models focused more on the adaptive
than on the innate response, which was fairly simplified or even
missing. In particular, none of these models included the
macrophage and natural killer immune functions explicitly and
innate the cytokine regulations were simplified. Moreover, none
took into account the regulatory adaptive response.
So we proposed an original model of the immune response to a
virus infecting pulmonary macrophages in the lung. We consid-
ered with particular attention the macrophage–virus interactions.
We highly detailed the mechanisms of the innate response and the
cytokine regulations. We included the cellular, the humoral and
the regulatory orientation of the adaptive response, as well as their
main functions. We represented the interactions between innate
and adaptive components. We applied our model to the Porcine
Respiratory and Reproductive Syndrome virus (PRRSv). PRRSv
is a major concern for the swine industry, as it is responsible for
significant economic losses worldwide [11,12]. This pathogen is of
particular interest because: (i) it exhibits a strong tropism for the
pulmonary macrophages [11–14]; (ii) it induces a prolonged
viremia thanks to its ability to hamper the immune response
[11,12,15]; and (iii) the infection and immune dynamics are highly
variable between hosts and viral strains. Depending on the studies,
various components of the immune response have been highlight-
ed as having an impact on PRRSv infection duration: (i) the
macrophage permissiveness and excretion rate; (ii) the levels of
antiviral and immuno-modulatory cytokines; and (iii) the balance
between the cellular, humoral and regulatory responses [16]. We
used our integrative model to identify the immune mechanisms
determining the infection duration and to explore the relevance of
these three assumptions, taking into account the variability in
pathogen virulence and host susceptibility.
First, we built our model by synthesising knowledge on the
immune mechanisms from published studies on PRRSv. Exper-
imental studies on PRRSv are numerous, but cannot provide all
our model parameter values. So we compiled data from the
literature by reviewing experimental and modelling studies on
pathogens targeting pulmonary macrophages and obtained large
value ranges for our model parameters. We explored the influence
of these parameters on the viral and macrophage dynamics by a
sensitivity analysis. We then identified a parameter set resulting in
realistic infection and immune dynamics. Finally, we explored the
influence of host susceptibility and viral virulence on the infection
outcome and we identified the associated immune mechanisms.
Methods
In this section, we first present the dynamic model and its
calibration, based on literature data. We then describe the
sensitivity analysis method used to quantify the influence of model
parameters on outputs of interest, among which the viral titer.
Finally, we define scenarios which represent the variability in host
susceptibility and strain virulence, in order to assess the impact of
this variability on the model outputs.
Model description
We built a deterministic dynamic model of ordinary differential
equations to simulate the infection and immune dynamics induced
by a pathogen targeting pulmonary macrophages in the lung. The
functional diagram of the model appears in Figure 1. We selected
the immune components and their interactions from current
knowledge on the immune mechanisms induced by pathogens
targeting pulmonary macrophages. Our modelling assumptions
are detailed and justified in the complete model description given
in Appendix S1. In particular, the cytokine regulations and
syntheses represented in our model, as well as the related literature
references, are summarised in Table S1 and Table S2 respectively.
The model is characterised by 18 state variables: the free viral
particles (V ); five effectors of the innate response: four macrophage
states and the natural killers (NK); three effectors of the adaptive
response and nine cytokines. A macrophage can either be susceptible
(MS ), phagocyting (MP), or infected; in this latter case, it is either latent
(ML) or excreting the virus (ME ). For the adaptive response, the
effectors represent the regulatory (Rr), humoral (Rh) and cellular (Rc)
responses. The nine cytokines included are the major pro-inflamma-
tory (IL1b, IL6, IL8), the innate antiviral (TNFa, IFNa) and the
immuno-regulatory (IFNc, IL10, TGFb, IL12) cytokines. IFNc also
exhibits an antiviral function. TNFa is generally considered as a pro-
inflammatory cytokine, but we were here more interested is its antiviral
function. The model describes the evolution over time of the state
variable concentrations in the lung.
The main processes that drive the evolution of these state
variables and that are integrated in the model are: the
phagocytosis of the viral particles by the macrophages (rate g);
the macrophage infection by the virus (rate b); the excretion of free
viral particles by the infected macrophages (rate e); the recruitment
(rate Am) and decay/migration of the macrophages (rates mM ); the
activation (rates a) and decay/migration of the other effectors
(rates m); the cytokine productions by the immune cells (rates r)
and their decay (rates mC ); the cytokine regulations (functions k).
Figure 2 gives a schematic representation of the model (without
regulations). Parameter descriptions and values are synthesised in
Immune Response Modelling to Assess Infection Duration
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Table 1. A complete description of the model and the corresponding
equations is given in Appendix S1. Here we describe the main
components of the model, illustrated by a few representative equations.
When a free viral particle encounters a susceptible macrophage
(1 in Figure 1), it can either be phagocyted (rate g, 2a in Figure 1),
resulting in viral destruction (3a in Figure 1), or it can infect the
cell (rate b, 2b in Figure 1), resulting in viral replication (3b in
Figure 1). The phagocytosis is amplified by antiviral cytokines
(TNFa, IFNa and IFNc) and inhibited by immuno-modulatory
cytokines (IL10 and TGFb, 2a in Figure 1). The infection (linked
to the macrophage permissiveness) is amplified by IL10 and
inhibited by innate antiviral cytokines (IFNa,TNFa) and TGFb
(2b in 1). Phagocyting macrophages revert to a susceptible status
after viral destruction (rate c); it is amplified by the antiviral
Figure 1. Functional diagram of the immune response to a virus targeting macrophages. Interactions between macrophages and virus (1)
result in macrophage activation by either phagocytosis (2a, amplified by antiviral cytokines and inhibited by immuno-modulatory cytokines) or
macrophage infection (2b, amplified by immuno-modulatory cytokines and inhibited by antiviral cytokines) releasing viral particles (3b). The activated
macrophages initiate the adaptive response (4a–c). IFNc and IL12 orient the adaptive response towards the cellular response (4a), whereas immuno-
modulatory cytokines orient the response towards the humoral and regulatory responses (4b–c). The cellular response and the natural killers are
responsible for the destruction of infected cells by cytolysis (7 & 10, respectively). The humoral response is responsible for the viral neutralisation
through antibodies (6). The recruitment of susceptible macrophages and natural killers is amplified by the pro-inflammatory cytokines (8a & 8b,
respectively). Cytokines are produced by activated macrophages (3d), natural killers (9) and adaptive cells (4a–c). These syntheses are regulated by
various cytokines.
doi:10.1371/journal.pone.0107818.g001
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cytokines and inhibited by IL10 (2a in Figure 1). Activated
macrophages (infected or phagocyting macrophages) produce
pro-inflammatory cytokines (3d in Figure 1), which amplify the
recruitment of susceptible macrophages (inflow Am, 8a in
Figure 1) [4,17–19]. Finally, susceptible macrophages undergo
natural decay (rate mnatM ) and TNFa-induced apoptosis (rate m
inf
M )
[20]. The resulting susceptible macrophage dynamics is shown in
Equation (1) and Figure 3.
The cytokine environment is not static in our model, as we
explicitely represented the evolution of the cytokine concentrations
over time. Cytokines are produced by activated immune cells. In
turn, they modulate the cellular functions through their recogni-
tion by specific receptors, inducing cascaded reactions within the
cells. The higher the cytokine concentration, the stronger the
effect. However, there is a limited number of cytokine receptors on
the cell surface, so the effect saturates above a given cytokine
concentration. We formalised the cytokine effects by a Michaelis–
Menten function (k) of the cytokine concentration (Ci) [8,21,22] as
follows:
k(Ci)~
K Ci
Cizk
,
where K represents the saturation factor and k the half-saturation
concentration. A cytokine can have three possible effects listed
below on a given flow (R).
N Activation: R k(Ci). The flow is only possible in the presence of
the cytokine and it increases with the cytokine concentration.
Figure 2. Conceptual model: state variables and flows without regulations. The state variables consist of: the free viral particles (V ); the
susceptible (MS), phagocyting (MP), latent (ML) and excreting (ME ) macrophages; the natural killers (NK); the cellular (Rc), humoral (Rh) and
regulatory (Rr) adaptive cells; the pro-inflammatory cytokines (IL1b, IL6 & IL8 ; grouped in the box), the innate antiviral cytokines (IFNa & TNFa) and
the immuno-regulatory cytokines (IL12, IFNc, IL10 & TGFb). The flows represented are: the inoculation of free viral particles (V0); the recruitment of
susceptible macrophages (Am); the activation of natural killers (aN ) and cells of the adaptive response (aR); the decay of the free viral particles (mv), the
macrophages (mM*), the natural killers (mN ), the adaptive cells (mR) and the cytokines (mC ); the macrophage state changes, i.e. phagocytosis (g and c),
infection (b) and transient excretion (l and n); the excretion of free viral particles by infected macrophages (e) and the cytokine syntheses by activated
immune cells (r*). For the sake of readability, the cytokine and cell regulations and not drawn and some parameter notations (marked with *) are
simplified.
doi:10.1371/journal.pone.0107818.g002
_MS~ Am ½1zk(IL12,IL6) ½1zk(IL8) / recruitment
{g MS V
½1zk(TNFa) ½1zk(IFNa) ½1zk(IFNc)
½1zk(IL10) ½1z k(TGFb) / phagocytosis
zc MP
½1zk(TNFa) ½1zk(IFNa) ½1zk(IFNc)
1zk(IL10)
/ phagocytosis ending
{b MS V
1zk(IL10)
½1zk(TNFa) ½1zk(IFNa) ½1zk(TGFb) / infection
{MS (m
nat
M zm
inf
M TNFa) / decay
(1)
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N Amplification: R ½1zk(Ci). The flow increases with the
cytokine concentration.
N Inhibition: R=½1zk(Ci). The flow decreases with the cytokine
concentration.
Regulations often involve several cytokines (Ci and Cj ), which
can act
N either independently: R ½k(Ci)zk(Ci) for an activation,
R ½1zk(Ci) ½1zk(Cj) for an amplification, or R=(½1z
k(Ci) ½1zk(Cj)) for an inhibition;
N or in synergy: R k(Ci,Cj)~R k(Ci) k(Cj) for an activation,
R ½1zk(Ci,Cj) for an amplification, or R½1zk(Ci,Cj) for an
inhibition.
For example, the recruitment of susceptible macrophages (8a in
Figure 1) is amplified by three cytokines, as shown in Equation (1):
two act in synergy (IL12 and IL6) and the third one acts
independently (IL8).
The dynamics of natural killers, given by Equation (2), offers a
more complex example of cytokines acting independently and in
synergy. We represented the dynamics of activated natural killers
and only included the regulations by the most influential cytokines
[4,19,23,24]. The recruitment of natural killers from the
bloodstream (rate aN , 8b in Figure 1) is activated by pro-
inflammatory cytokines: IL12 and IL6 co-activate the recruitment,
whereas IL8 acts independently. Natural killers are then activated
by IFNc and IL12, whereas IL10 inhibits the activation. They are
submitted to natural death or/and migration (rate mR). Activated
natural killers destroy infected cells (10 in Figure 1) and synthesise
IFNc (9 in Figure 1) [4,19,23,24].
N_K~ aN
½k(IL12,IL6)zk(IL8) ½k(IFNc)zk(IL12)
½1zk(IL10) / recruitment & activation
{mR NK / decay
ð2Þ
Activated macrophages present the viral antigens to the
adaptive cells (3c in Figure 1). The subsequent orientation of the
adaptive response depends on the immuno-regulatory cytokines
(4a – c in Figure 1). We represented the adaptive response by three
effectors corresponding to the three main orientations: cellular,
humoral and regulatory responses [1,4,13,25–31]. As for the
natural killers, we only represented the dynamics of the activated
effectors. Based on the model proposed by Yates et al. for the
regulation of T helper cell populations [31], we synthesised the
dynamics of each adaptive effector by three steps: activation by
activated macrophages (rate aR), proliferation (rate pR) and decay.
We represented the regulations of the activation and proliferation
steps by the most influential cytokines: IFNc, IL12, IL10 and
TGFb (assumptions and references detailed in Appendix S1). The
decay includes the natural decay (rate mR) and the Activation
Induced Cell Death (AICD) induced by the interaction with a type
1 T helper cell from the Rc compartment (basic rate dRc ) [31].
N Cellular response: Rc represents the type 1 T helper cells and
the cytotoxic lymphocytes. Its dynamics is described in
Equation (3). Activation is amplified by IFNc and IL12 and
inhibited by IL10; proliferation is activated by IFNc and IL12
and inhibited by IL10 and TGFb (4a in Figure 1). Rc
synthesises IFNc (5a in Figure 1) and destroys infected
macrophages (7 in Figure 1).
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N Humoral response: Rh represents the type 2 T helper cells, the
B lymphocytes and the antibodies. Activation is amplified by
IL10 and inhibited by IFNc and IL12; proliferation is activated
by IL10 and inhibited by IFNc, IL12 and TGFb (4b in
Figure 1). Rh synthesises IL10 (5b in Figure 1) and neutralises
free viral particles through antibodies (6 in Figure 1).
N Regulatory response: Rr represents the regulatory T cells.
Activation is amplified by IL10 and TGFb and inhibited by
IFNc and IL12; proliferation is activated by TGFb and
inhibited by IL10, IFNc and IL12 (4c in Figure 1). Rr
synthesises IL10 and TGFb (5c in Figure 1).
Simulations. The model was implemented in Scilab 5.3.3
(http://www.scilab.org/). For all simulations, the initial conditions
were set to represent an initial viral inoculation in a PRRSv-naive
host and were chosen as follows: V (0)~V0[½104,107TCID50=ml
for the viral titer; MS(0)~5 10
5cells=ml for the susceptible
macrophages; all remaining variables were set to zero. The model
parameters are summarised in Table 1.
Model calibration
Published experimental data on PRRSv infection (reviewed in
[11,12,16,32–37]) are highly heterogeneous and differ on: (i) the
monitoring duration, (ii) the measured immune components, (iii)
the viral strain, (iv) the pig genotype. Moreover, among the
variables included in our model, only a few were monitored in
each experimental study and there were few measures over time.
Consequently, based on these data, classical parameter estimation
methods were not suitable to calibrate our model and we had to
design an ad hoc procedure.
The first step of the calibration procedure was to synthesise data
from experimental infections to identify the variation ranges of our
model parameters. When PRRSv studies could not provide
parameter values, we reviewed models applied to tuberculosis
and influenza. The value ranges obtained for the model
parameters and the corresponding references are given in Table 1
(ranges defined by the minimum and maximum tested values).
The second step was to explore the parameter space defined by
these value ranges. We used a design of experiments which is
described in the Sensitivity analysis section below. The simulations
resulting from this exploration exhibited very contrasted outputs
(Figures S2–S4). So the third step was to define the characteristics
of the infection and immune dynamics corresponding to a realistic
response to PRRSv infection. We chose to represent an average
response as our reference scenario (S0). This step is detailed below.
Finally, the fourth step was to select a parameter set corresponding
to this reference scenario. We used the sensitivity analyses
presented below to focus first on the most sensitive parameters,
i.e. parameters which had the greatest impact on the model
outputs.
For the reference scenario, we chose to represent the infection of
a weaned pig by a single PRRSv inoculation. Weaned pigs are
supposed to be naive to PRRSv and to have lost their maternal
immunity. In experimental PRRSv infection studies, the inocula-
tion dose ranged between 4 and 7 log10(TCID50=ml) [38,39]; we
chose an inoculation dose of 6.3 log10(TCID50=ml). PRRSv
infection usually lasts between 28 to 42 days in the blood
[12,16,40] and around 56 days in the lung [12]. However, the
infection duration is highly variable between pigs and viral strains
and can be higher than 200 days [16,41]. So we chose an infection
duration in the lung of around 70 days. Few quantitative data are
available for the immune dynamics. The cytokine levels are highly
Figure 3. Susceptible macrophage dynamics with cytokine regulations. The state variables represented are: the free viral particles (V ); the
susceptible (MS), phagocyting (MP) and latent (ML) macrophages; the pro-inflammatory cytokines (IL6 & IL8), the innate antiviral cytokines (IFNa &
TNFa) and the immuno-regulatory cytokines (IL12, IFNc , IL10 & TGFb). All processes that impact the susceptible macrophages are included:
recruitment (Am), decay (mM , simplified notation), phagocytosis (g and c) and infection (b); their positive and negative regulations by cytokines are
also drawn.
doi:10.1371/journal.pone.0107818.g003
_Rc~ aR ½MPzMLzME  ½1zk(IFNc) ½1zk(IL12)
1zk(IL10)
/ activation
zpR Rc
½k(IFNc)zk(IL12)
½1zk(IL10) ½1zk(TGFb) / proliferation
{mR Rc{dRc Rc
2 / decay
(3)
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variable between studies [11,13] and poorly documented in the
lung. Their magnitude ranges between 10{1 and 103 pg/ml. IL10
levels in response to PRRSv infection and other respiratory
pathogens are similar. They are higher than the levels of pro-
inflammatory, antiviral (innate and adaptive) and other immuno-
regulatory (IL12, IFNc and TGFb) cytokines. Without infection,
macrophage concentrations in the lung were observed around 105
cells/ml. To our knowledge, only one experimental study tracked
infected macrophages, which peaked during the first days of
PRRSv infection at around 40% among all macrophages [39].
Little is known about the phagocyting macrophages, except that
the phagocyting state is transient and that PRRSv promotes
macrophage infection over phagocytosis [42,43]. Reported levels
of natural killers during PRRSv infection were low compared to
other respiratory pathogens [15,33]. The humoral response to
PRRSv infection is similar to other respiratory pathogens, whereas
the cell-mediated immunity is delayed and weak. The regulatory
response has been poorly studied and results are controversial
[13,44–46]. Moreover, the orientation of the adaptive response
varied considerably between studies. Consequently, we chose a
balanced adaptive response orientation for our reference scenario.
Sensitivity analysis
We were interested in identifying the most influential param-
eters on the infection dynamics thanks to a global sensitivity
analysis. Consequently, the first two outputs selected were the viral
titer (V ) and the percentage of infected macrophages among the
total concentration of macrophages (%MI~%(MLzME)). We
were also interested in characterising the phagocytosis activity,
which directly limits the macrophage infection. The phagocytosis
is a transient macrophage state, which explains why, whatever the
parameter combination selected in the parameter ranges, the
percentage of phagocyting macrophages (%MP) was low com-
pared to the percentage of infected macrophages (%MI ) at any
time during the course of infection (Figure S1). However, it does
not mean that the phagocytosis activity was necessarily low. We
compared the phagocytosis flow (susceptible macrophages becom-
ing phagocyting macrophages per unit of time) and the infection
flow (susceptible macrophages becoming infected macrophages
per unit of time) during the course of infection. Depending on the
parameter values, the phagocytosis inflow was higher or lower
than the infection inflow (Figure S1). Consequently, the cumula-
tive number of phagocyting macrophages (cMP), which corre-
sponds to the phagocytosis flow integrated over time, is a good
representation of the phagocytosis activity. So we selected this
variable as the third output of interest. We used a design of
experiments to define which simulations to run. The resulting
outputs were analysed to produce the sensitivity indices, which
quantify the influence of the parameters on the model outputs. We
used the R software, version 3.0.2, (http://www.r-project.org/) for
these analyses.
We selected 30 among the 31 model parameters for the
sensitivity analysis. We did not include the proliferation rate of the
adaptive effectors (pR), because the combination of high pR and
high IL10 synthesis rates led to the explosion of the Rh and Rr
dynamics, which resulted in a numerical integration failure of the
model. For each of the 30 parameters, we chose to test three values
among the value range identified in the calibration procedure: the
lower and upper bounds of the range, as well as an intermediate
value (Table 1). Testing all parameter combinations, i.e. a
complete factorial design, would have required 330 simulations,
which was not feasible. Consequently, fractional factorial designs
were used instead. A preliminary analysis was conducted to
estimate the main effects of the 30 parameters on the model
outputs, without taking into account the interactions between
parameters. A fractional design of size 243, determined as the
minimum size to correctly estimate the main effects, was
implemented: 243 parameter combinations were defined and the
corresponding simulations were performed and analysed. From
this preliminary analysis, the ten most influential parameters on
each of the three outputs were identified. We then performed a
sensitivity analysis on each output, aiming at estimating the main
effects and two-parameter interactions of the corresponding ten
most influential parameters, to which we potentially added extra
parameters assumed to have an impact on the corresponding
output. For instance, we added the macrophage mortality rates for
the %MI output. We selected 17 parameters for the viral titer, 10
parameters for the cumulative MP and 21 parameters for the
percentage of infected macrophages (Figure 4). The smallest
design that correctly estimates the main effects and two-parameter
interactions for 21 parameters (%MI output) requires 3
8~6561
parameter combinations. We chose to use the same design size for
all outputs, so 6561 simulations were performed and analysed for
each of the three outputs. The Planor R package (http://cran.r-
project.org/web/packages/planor/index.html) was used to con-
struct the fractional designs.
Sensitivity indices were calculated for each parameter on each
output in the preliminary analysis (30 parameters | 3 outputs)
and the subsequent analyses taking into account two-factor
interactions. Sensitivity indices quantify the fraction of output
variance among simulations explained by the variation of each
parameter within its value range [47]. Our model outputs being
time-dependent variables, we used a method adapted to multi-
variate outputs, which is based on a decomposition of the variable
using a principal component analysis (PCA) [48]. As a result of the
PCA, an inertia proportion is attributed to each component. It
represents the variability among simulations carried by the
component. Moreover, each simulation is given a "score" on each
component, a scalar which represents the projection of the
simulation on the component. Then, for each component, an
ANOVA is performed on these scores to estimate the influence of
each parameter on the output. The sensitivity index associated
with each term, main effect of a parameter or interaction between
parameters, is defined as the ratio between the sum of squares
corresponding to that term and the total sum of squares. Finally, a
generalised sensitivity index (GSI) is calculated for each term (main
effect or interaction) as the the sum of the sensitivity indices
corresponding to that term on each PCA component, weighted by
the inertia of the component. The total generalised sensitivity
index (tGSI) of a parameter is defined as the sum of the sensitivity
indices corresponding to this parameter (main effect mGSI plus
sum of interactions involving the parameter iGSI). We used the
Multisensi R package (http://cran.r-project.org/web/packages/
multisensi/index.html) for this analysis.
GSI results are presented below. For each output, key
parameters are defined as the most influential parameters for
which the cumulative total GSI is higher than 75%.
Variability in host susceptibility and strain virulence
PRRSv exhibits an important genotypic diversity associated
with various virulence levels [13]. The European genotype is less
virulent than the American genotype [35], but the virulence also
differs among strains within a genotype [49]. The highly virulent
strains are associated with a prolonged viremia, a high viral
replication rate and a high humoral response [50]. Moreover, the
genetic component of the host susceptibility to PRRSv has been
demonstrated [51,52]. Pig susceptibility can also depend on other
factors such as herd management. The more susceptible pigs
Immune Response Modelling to Assess Infection Duration
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develop prolonged viremia, with low titers of neutralising
antibodies [10,52], probably linked to a high macrophage
permissiveness and/or specific cytokine profiles [51].
Both viral virulence and pig susceptibility seem linked to: (i) the
virus capacity to infect the cell and replicate, (ii) the host capacity
to synthesise antiviral vs immuno-modulatory cytokines in
response to PRRSv infection, and (iii) the activation and
orientation of the adaptive response. Recent studies hypothesise
that these variations of the immune dynamics are due to cascaded
reactions initiated by the macrophage–virus interactions
[33,34,49,51]. Consequently, we focused on the macrophage
infection and cytokine synthesis capacities. Both macrophage
permissiveness and viral replication impact the cytokine synthesis,
which in turn regulates them. Discriminating the respective
influence of the macrophage permissiveness and the cytokine
synthesis rate is very difficult experimentally, but it can be
achieved by a modelling approach. To explore the influence of
both mechanisms, scenarios were defined by varying a selection of
parameters chosen according to the sensitivity analysis results and
to the hypotheses presented above. We tested 19 graduated values
of: (i) the macrophage permissiveness, promoting either the
phagocytosis (scenarios S0 to S1: S0?S1), or the macrophage
infection and viral excretion (scenarios S0?S2); and (ii) the
cytokine synthesis rates, promoting either the antiviral cytokine
synthesis (scenarios S0?SB), or the immuno-modulatory cytokine
synthesis (scenarios S0?SA). Scenarios are defined in Table 2.
Compared to the reference scenario (S0), scenarios S0?S1 and
S0?SB correspond to low host susceptibility and strain virulence,
whereas scenarios S0?S2 and S0?SA correspond to high
susceptibility and virulence. The parameter ranges were set to
cover the variation range of the viral titer reported in the
literature.
We used the area under the curve (AUC) to synthesise our
model outputs. As the shapes of the immune and viral output
curves were similar across the scenarios, characterising each curve
by a well-chosen number was appropriate and facilitated the
comparisons between scenarios. Choosing the AUC was relevant,
Figure 4. Generalised sensitivity indices (GSI) for the three outputs of interest. A: Viral titer V (R2~0:93). B: Cumulative number of
phagocyting macrophages cMP (R
2~0:92). C: Percentage of infected macrophages among all macrophages %MI (R
2~0:96). Total GSI (bars) are
represented for an output-dependent selection of influential parameters. For each parameter, the total GSI is split into main parameter effect (black
bar) and the sum of two-parameter interactions involving the parameter (grey bar). R2 corresponds to the fraction of output variance explained by
the parameters. NB: As the two-parameter interactions are counted for both parameters, the sum of the total GSI is higher than 100%.
doi:10.1371/journal.pone.0107818.g004
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as it reflects the entire curve [53]. Relative AUC were defined as
percentages of output AUC among a group of outputs.
Several linear regressions were performed to extract trends from
our results and facilitate the interpretations. In particular, to
highlight the links between immuno-regulatory cytokines and the
orientation of the adaptive response, we performed linear
regressions between (i) the relative AUC of relevant cytokines
and (ii) the relative AUC of the adaptive response effectors (Rc, Rh
& Rr). To highlight the immune mechanisms determining the
infection duration, we performed linear regressions between (i) the
AUC of relevant immune components, which are assumed to have
a strong influence on the infection duration in the literature and (ii)
the infection duration. We used the R software, version 3.0.2, for
these analyses.
The infection duration is defined as the time elapsed between
the initial viral inoculation and the virus clearance. In our model,
we assumed that there was no more infection when the virus titer
was below 0:01 TCID50=ml.
Results
Model calibration and sensitivity analysis
The reference scenario (S0) was characterised by a 72-day
infection duration, an infected macrophage peak at 40% of the
total macrophage concentration, a balanced adaptive response
orientation and high IL10 levels compared to antiviral and pro-
inflammatory cytokine levels. Its parameter values are given in
Table 1 and it is represented in Figue 5 (black curves).
In the preliminary sensitivity analysis, with all 30 parameters
but no interactions between parameters, the variance explained by
the parameters retained for the main sensitivity analysis on each
output was 89% for the viral titer, 89% for the cumulative number
of phagocyting macrophages and 70% for the percentage of
infected macrophages. The results of the main sensitivity analyses
with two-parameters interactions are shown in Figure 4; for each
output, the total global sensitivity index defined for each
parameter is split into the parameter main effect and its
interactions. At least 92% of the total output variance was
explained by the parameters and two-parameter interactions for
all three outputs. Three key parameters (explaining together more
than 75% of the variance) were identified for each output. Their
impact is detailed in Table 3. Most of them were involved in
macrophage–virus interactions. The infection rate b was a key
parameter for the three outputs of interest. The excretion rate e
was a key parameter for the viral titer and the percentage of
infected macrophages. The phagocytosis rate g was a key
parameter for the viral titer and the cumulative number of
phagocyting macrophages. The remaining key parameters were
the inoculation dose V0 for the cumulative number of phagocyting
macrophages and the synthesis rate of innate antiviral cytokines
rAi for the percentage of infected macrophages. The main effects
of the key parameters ranged between 0.4% (b on the viral titer)
and 28% (g on the viral titer). Key parameters also exhibited high
interactions (e.g. 27% for interactions involving b on the
percentage of infected macrophages), in particular between two
key parameters (results not shown).
The initial inoculation dose V0 was a key parameter for the
cumulative number of phagocyting macrophages (tGSI = 35%),
but neither for the viral titer (tGSI = 11%), nor for the percentage
of infected macrophages (tGSI = 5%). This result can be explained
by the fact that the phagocytosis activity mostly occurs during the
first days of the infection, whereas the viral titer and infected
macrophages are impacted all along the infection course (Figures
S2–S4).
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The infection rate b had less impact on the viral titer variability
(tGSI = 19.4%, mGSI = 0.4%) than the phagocytosis rate g
(tGSI = 39%, mGSI = 28%) and the excretion rate e (tGSI = 22%,
mGSI = 10%). Macrophage infection results in viral excretion and
has a positive impact on the free viral particles, but it is attenuated
by the virus mobilisation by infected macrophages.
The infection rate b and the excretion rate e exhibited a strong
interaction on the viral titer and the percentage of infected
macrophages (GSI around 8%). Indeed, the viral replication needs
macrophages to be infected and conversely, macrophage infection
is induced by free viral particles which are released through viral
excretion.
Impact of host susceptibility and strain virulence on the
infection resolution and associated immune mechanisms
The 37 scenarios corresponding to graduated levels of host
susceptibility and strain virulence were simulated. The results are
illustrated in Figure 5 and summarised in Table 4. The infection
durations (52–118 days according to the scenario) were consistent
with literature data [12,16,40,41]. All scenarios had a notable
impact on the infection duration. The scenarios related to
macrophage permissiveness (S1?S2) induced higher differences
in infection duration than the scenarios related to the cytokine
synthesis (SB?SA), even if the parameter variations were lower
for scenarios S1?S2 than for scenarios SB?SA (Table 2).
Consequently, the infection duration seems more sensitive to the
parameters involved in the macrophage permissiveness than the
antiviral cytokine synthesis rate.
The dynamics of immune components were similarly bell-
shaped but differed quantitatively. More severe and longer
infections were overall associated with higher levels of immune
responses (Figure 5), but the relative proportions of the immune
components varied (Table 4).
Concerning the innate response, we found a significant and
positive correlation (R2~0:97) between the levels of infected
macrophages and IL10, a cytokine which amplifies macrophage
permissiveness and viral replication (results not shown).
There was no evidence of a link between the proportions of IL12
and TGFb and the orientation of the adaptive response. The
proportions of IL10 and IFNc, however, were linked to the
adaptive response orientation (Table 4 & Figure 5). The propor-
tion of IL10 among IL10 and IFNc was negatively correlated with
Figure 5. Immune and infection dynamics for variable host susceptibility and strain virulence. Evolution of twelve variables (panels A to
L) during the first 30 days of infection (unless specified). A: Viral titer (V , during 120 days). B: Phagocyting macrophages (MP). C: Infected
macrophages (MI~MLzME ). D: Pro-inflammatory cytokines (Pi~IL1bzIL6zIL8). E: Innate antiviral cytokines (Ai~TNFazIFNa). F–I: Immuno-
regulatory cytokines (F: IL12, G: IFNc, H: IL10 and I: TGFb). J: Adaptive cellular effectors (Rc). K: Adaptive humoral effectors (Rh). L: Adaptive
regulatory effectors (Rr). For each variable, the left plot corresponds to scenarios SB?SA, in which the antiviral cytokine synthesis is higher (S0?SB,
red) or lower (S0?SA, magenta) than in the reference scenario (S0, black). The right plot corresponds to scenarios S1?S2, in which the macrophage
permissiveness is lower (S0?S1, green) or higher (S0?S2, blue) than in the reference scenario (S0, black). Low susceptibility and virulence levels
correspond to scenarios which promote the antiviral cytokine synthesis (red) and scenarios with low macrophage permissiveness (green). High
susceptibility and virulence levels correspond to scenarios which promote the immuno-modulatory cytokine synthesis (magenta) and scenarios with
high macrophage permissiveness (blue) Scenarios are defined in Table 2.
doi:10.1371/journal.pone.0107818.g005
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the percentage of cellular response (R2~0:91) and positively
correlated with both the humoral (R2~0:94) and regulatory
responses (R2~0:84).
Scenarios S1?S2 resulted in immune dynamics rather close to
the reference scenario, except for IFNc levels (Figure 5). On the
one hand, high infection capacities (S0?S2) resulted in long
infection durations despite high levels of IFNc (Figure 5) and the
adaptive response was oriented towards the cellular response
(%Rc~40%, Table 4). However, IFNc percentages were similar
to the reference scenario. On the other hand, low infection
capacities (S1?S0) resulted in short infection durations despite
high percentages of IL10 and the adaptive response was oriented
towards the humoral response (%Rh~41%,Table 4). IL10 levels
were similar to the reference scenario (Figure 5).
Scenarios SB?SA resulted in more contrasted immune
dynamics (Figure 5) and influenced the adaptive response orien-
tation more than scenarios S1?S2 (Table 4). Low antiviral
capacities (S0?SA) resulted in long infection durations associated
with high levels (Figure 5) and percentages of IL10, and co-
dominant humoral and regulatory responses (Table 4). High
antiviral capacities (SB?S0) resulted in short infection durations
associated with high levels (Figue 5) and percentages of IFNc, and
an orientation towards the cellular response (Table 4).
To extract trends more easily from these results, we investigated
the correlations between the infection duration and the levels of
seven key immune components of interest: infected and phago-
cyting macrophages, innate antiviral and pro-inflammatory
cytokines and percentages of IL10 and IFNc (Figure 6). Consid-
ering all scenarios together, no significant correlations could be
extracted. Consequently, we split the scenarios in two groups:
those with varying macrophage capacities (S1?S2) and those with
varying cytokine synthesis capacities (SB?SA). All correlations
were significant. The AUC of infected macrophages and pro-
inflammatory cytokines were positively correlated with the
infection duration for both groups. Otherwise, both groups
exhibited opposite correlations.
In summary, low virulence and susceptibility scenarios induced
short infection durations by promoting the phagocytosis or the
synthesis of antiviral cytokines. On the contrary, high virulence
and susceptibility scenarios resulted in long infection durations by
promoting the infection and viral excretion or the synthesis of
immuno-modulatory cytokines. Infection durations were always
positively correlated with the levels of infected macrophages and
pro-inflammatory cytokines. We observed that longer durations
were associated with higher percentages of infected macrophages
among activated macrophages. However, high levels of antiviral
cytokines compared to immuno-regulatory cytokines, inducing a
dominant cellular response, can be associated with either (i) long
(scenarios related to macrophage permissiveness) or (ii) short
infection durations (scenarios related to cytokine synthesis
capacities).
Discussion
Modelling approach
In this paper, we presented an integrative dynamic model of the
immune response in the lung to a virus targeting pulmonary
macrophages: the PRRSv. The complexity level of the model is a
good compromise between detailed intra-cellular models which
focus on specific immune mechanisms and global models which
give general trends [8]. Our model offers a comprehensive
representation of the interactions between the virus and the
immune response, which is necessary to explore the influence of
the immune mechanisms on the infection duration. It is an original
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approach that takes into account the innate mechanisms, the
adaptive response orientation and their complex interactions and
regulations involving cytokines. We chose to represent the
activation and orientation of the adaptive response, even if they
occur outside the lung, because they interact with the immune and
infection dynamics. Therefore, we did not detail the intermediate
differentiation and proliferation steps of the adaptive response, but
we represented its main immune functions and regulations. We
hence obtained a realistic qualitative dynamic of the adaptive
response. We did not represent the dendritic cells, major antigen
presenting cells which influence the adaptive response activation
and orientation. These cells maturate during their migration from
the infection site to the lymph nodes, where they synthesise
cytokines. They influence the infection dynamics through the
cytokines they synthesise, which is consequently negligible in the
lung. Moreover, dendritic cells and macrophages drive the
adaptive response orientation in a similar way. As our model
does intend to represent the orientation of the adaptive response
between the different types and not the quantitative levels of
adaptive cells, we trust that our simplification did not distort the
results. This simplification is even more appropriate when dealing
with PRRSv, as the virus also infects dendritic cells. Dendritic cells
and macrophages hence have very similar dynamics and impacts
during PRRSv infection [54,55].
The model was built to describe a single infection by a stable
pathogen at the within-host scale. We used it to study the impact
of PRRSv strains, which exhibit various virulence levels. Our
model could be easily adapted to other pathogens targeting
pulmonary macrophages, such as influenza viruses. As influenza
also infects epithelial cells, these target cells would have to be
included in the model. As for other pathogens, the immune
dynamic part of our model constitutes a good basis to study the
innate response, given the fact that it is strongly simplify in most of
the published models.
Model calibration and scenario definition
The variation range of our model parameters were based on
literature data. To complement these data and deal with the high
variability on the parameter values and output levels, we
developed an ad hoc method based on large parameter space
exploration and sensitivity analysis. We defined a reference
scenario, which corresponds to an average dynamics within the
observed immune and infection dynamics. To study the impact of
host and strain variability, we also defined parameter sets based on
published assumptions and resulting in infection durations which
were consistent with the literature [12,16,40,41]. However, a
quantitative calibration based on the viral dynamics and immune
response data was not feasible. The levels of strain virulence and
susceptibility of pigs are not quantified, the viral strains and pig
breeds are not always informed and only few combinations of
breeds and strains have been tested, so the comparisons between
Table 4. Summary of the virus and immune dynamics for variable host susceptibility and strain virulence.
Susceptibility and virulence:
low reference high
S1 SB S0 SA S2
Virus – Infection duration [d] 52 57 72 93 118
Innate response – AUC
MP=(MIzMP) [%] 1.4 1.6 0.5 0.2 0.2
MP 0.030 0.008 0.009 0.030 0.008
MI 2.1 0.48 3.5 18 5.1
NK 71 15 225 866 559
Pi~IL1bzIL6zIL8 1.2 0.28 2.4 10.8 3.6
Ai~IFNazTNFa 9 26 16 7 23
Adaptive response – AUC
IL12zIFNczIL10zTGFb 3.2 2.5 6.6 107 10.3
RczRhzRr 108 36 124 455 146
Cytokines – relative AUC [%]*
IL12 21 9 16 2.8 14
IFNc 1 85 22 0.2 30
IL10 71 4.5 59 93 54
TGFb 7 0.5 3 4 2
Orientation – relative AUC [%]*
Rc 23 54 32 14 40
Rh 41 23 36 43 32
Rr 36 23 32 43 28
Scenarios S1: low macrophage permissiveness; SB: high antiviral and low immuno-modulatory cytokine synthesis; S0: reference; SA: high macrophage permissiveness;
S2: low antiviral and high immuno-modulatory cytokine synthesis. AUC (area under the curve) units: macrophages [105 d=ml], other cells [d/ml], cytokines [102 pg:d=ml].
Macrophages: infected (MI ), phagocyting (MP). Adaptive effectors: cellular (Rc), humoral (Rh) and regulatory (Rr) orientations.
*Relative AUC are defined within a group of outputs (e.g. the four cytokines IL12 , IFNc , IL10 and TGFb) as the AUC of the outputs expressed as percentages of the sum
of the AUC within the group.
doi:10.1371/journal.pone.0107818.t004
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our scenarios and the literature are limited, especially for the
immune response.
The sensitivity analysis highlighted five key parameters with a
strong influence on the macrophage and virus dynamics: the viral
inoculation dose V0, the viral excretion rate e, the macrophage
infection rate b, the phagocytosis rate g and the antiviral cytokine
synthesis rate rAi . The inoculation dose is measured in experi-
mental studies but is difficult to assess in field conditions. The
other three key parameters are not easy to inform. Distinguishing
between infected and phagocyting macrophages is an experimen-
tal challenge, so their dynamics are rarely observed and the related
parameter values are not measured in the literature. Further
experimentation would be needed to track the dynamics of our
outputs of interest, especially viral titer and ideally both infected
and phagocyting macrophages, or at least activated macrophages.
The sensitivity analysis also exhibited high interactions between
parameters, which partly explain the difficulties encountered to
calibrate the model.
In terms of viral dynamics, the simulated infection durations
ranged between 52 and 118 days according to the scenarios.
Experimental studies show that the resolution generally occurs in
the serum between 28 and 42 days after a PRRSv infection
[12,16,40] and in the lung after 56 days on average [12,56–59].
Infections longer than 240 days have been observed [16].
Consequently, the variation range of the simulated infection
durations is realistic. Few studies measure the infection duration in
the sera and in the lung simultaneously [40,60,61]. Combining
these studies, we estimated that the infection duration in the lung is
around 1.6 times longer than in the sera. This approximation
allowed us to compare the infection duration in the lung from our
simulation results to the infection duration in the blood (viremia)
from experimental results. Few experimental studies focus on the
response variability due to the viral strain or pig breed
susceptibility. In a resistant pig breed, the viral load was around
35 days in the sera (estimated around 56 days in the lung) [52] and
around 52 days in the lung with a low virulent strain [62].
Conversely, a more susceptible pig breed showed a 72-day viremia
(estimated around 115 days in the lung) [52]. Infections by a highly
virulent strain resulted in a viremia of 36 days (estimated around
58 days in the lung) [59] or the presence of viral particles in the
lung for more than 67 days [63]. Our results were consistent with
these data, but exhibited a larger range of infection durations.
In terms of immune response, the main trends found in the
literature are the following: high virulence and susceptibility are
associated with (i) a high activation of the immune response [64];
(ii) a dominant humoral response [38] with high levels of IL10; (iii)
a lower cellular response with low levels antiviral cytokines
[33,34,50,64,65]. However, trends (ii) and (iii) do not always hold.
Some reviews point out that levels of antiviral and IL10 cytokines
are highly variable between hosts and viral strains [11,13]. An
infection by a highly virulent strain can result in high levels of
IFNc [59]. A strong cellular response is not necessarily correlated
with a short infection duration [57]. Our results are qualitatively
consistent with these data: high virulence and susceptibility
scenarios were associated with high levels of the immune response
and various orientations of the adaptive response. A common
trend detected throughout all scenarios was the correlation
between IL10 and the infected macrophages. Unlike the infected
macrophages, IL10 can be easily be measured. However, this result
should be confirmed by experimentation before using IL10 as a
proxy for infected macrophages. We also found that high levels of
pro-inflammatory cytokines were associated with longer infections.
Figure 6. Linear regressions between the infection duration and immune components of interest. The immune components selected are
the area under the curve (AUC) of A: infected macrophages (MI~MLzME ), B: innate antiviral cytokines (Ai~TNFazIFNa), D: pro-inflammatory
cytokines (Pi~IL1bzIL6zIL8), and E: phagocyting macrophages (MP); and the relative AUC of C: IFNc and F: IL10. Two regressions were
performed for each component: (i) for scenarios SB?SA (dark red), in which the antiviral cytokine synthesis is higher (S0?SB, red dots) or lower
(S0?SA, magenta dots) than in the reference scenario; (ii) for scenarios S1?S2 (dark blue), in which the macrophage permissiveness is lower (S0?S1,
green dots) or higher (S0?S2, blue dots) than in the reference scenario. Scenarios are defined in Table 2.
doi:10.1371/journal.pone.0107818.g006
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It has been suggested that inflammatory responses in the lung are
an indicator of the severity and duration of the PRRSv infection
rather than an indicator of the immune response efficacy [17].
Assessing the impact of variability in host susceptibility
and strain virulence
The strain virulence and pig susceptibility variability impact the
infection duration, but the underlying mechanisms are still
incompletely understood. Several hypotheses are formulated to
explain PRRSv infection duration. Early immunological findings
link prolonged viremia with (i) a weak innate antiviral response, (ii)
high levels of immuno-modulatory cytokines (IL10 and TGFb) and
(iii) low levels of IFNc, resulting in the orientation towards an
inefficient humoral response; in contrast the cellular response
could be protective. These results are challenged in more recent
studies. All this knowledge is synthesised and discussed in terms of
between-host and between-strain variability in recent reviews
[16,33,34,37]. In the following discussion sections, we confront our
simulation results to the above-mentioned hypotheses.
Innate response. PRRSv has been reported to have various
negative effects on innate immune functions, which probably
contribute to the long survival of the virus in infected pigs. It
suppresses the phagocyting activity, it fails to elicit any significant
innate antiviral cytokines and it alters of the innate cytokine
patterns compared to other respiratory pathogens [33,37].
Consequently, we could expect negative correlations between the
infection duration and both innate antiviral cytokines (Ai) and
phagocyting macrophages (MP). However, we found that long
PRRSv infections were correlated as follows: either positively with
Ai and negatively with MP, or positively with MP and negatively
Ai. To explain these questioning results, we need to consider the
levels of the other immune components and the parameter values
used.
For scenarios S1?S2, we gradually promoted the infection and
excretion while limiting the phagocytosis. It resulted in longer
infection durations, a high increase of Ai, a decrease of MP and a
moderate increase of infected macrophages (MI ). As Ai are mainly
synthesised by MI , promoting infection results in increasing Ai. In
turn, Ai inhibits the infection and should reduce MI . However,
promoting the excretion and limiting the phagocytosis increase the
free viral particles (V ) and MI . This last mechanism was dominant
in these scenarios and countered the effect of Ai.
For scenarios SB?SA, we gradually promoted the synthesis of
immuno-modulatory cytokines (IL10 and TGFb) and limited the
synthesis of Ai and IFNc. It resulted in longer infection durations,
an increase of MP and a high increase of MI and IL10. Promoting
IL10 and TGFb should increase the infection and reduce the
phagocytosis, both contributing to an increase of V . In turn, V
activates the phagocytosis and infection. This last mechanism was
dominant in these scenarios and countered the cytokine effect. As
a net result, MP increased.
Our results suggest that despite high correlations between
components of the innate response and the infection duration,
measuring the innate response alone is insufficient to explain and
predict the infection duration.
Adaptive response. The orientation towards the cellular,
humoral or regulatory responses is supposed to have a high
influence on the infection duration, but the mechanisms governing
the orientation still need more insight. In experimental studies, the
orientation towards the humoral and cellular responses is usually
approximated by the levels of IL10 and IFNc respectively.
However, few studies consider the cellular and humoral responses
simultaneously, as well as the associated cytokines, and most
studies neglect the regulatory response. Reviews on PRRSv
infection suggest that high levels of IL10 are capable of shifting
the immune response towards a humoral response and that in the
absence of IFNc, there is no cellular response [16,33]. As the
neutralisation of IL10 inhibits the regulatory response [37], levels
of IL10 and regulatory response are assumed to be linked. In our
model, the three orientations were represented, as well as their
regulations and interactions. We found that the orientation of the
adaptive response did not depend on specific cytokine levels, but
on the proportions of IFNc and IL10. This result is consistent with
the literature, as it points out the crucial role of IFNc and IL10 on
the adaptive response orientation. However, it also points out the
limits of the usual approximation of the adaptive response
orientation by IFNc or IL10 levels.
The cellular response is considered as protective against a wide
variety of viral infections but its influence is controversial in the
case of PRRSv infections [16,33]. Reviews suggest that the
suppression of IFNc may have little influence on the in vivo
disease progression [16,66]. Moreover, long-term persistence of
the virus in the host associated with a strong cellular response has
been observed [33]. Both findings suggest that the cellular
response alone cannot curtail the infection. Correlations between
the strength of the cellular response and the PRRSv infection
duration are highly variable between hosts and strains [34]. We
also found that a dominant cellular response and high percentages
of IFNc can be associated with either long or short infection
durations. Scenarios SB?SA are consistent with the usual
assumption that confers a protective role to the cellular response.
However, in scenarios S1?S2, long infection durations were
associated with a dominant cellular response. To explain this
result, we need to consider simultaneously the levels of the other
immune components and the parameter values used. Long
infection durations were associated with high levels of IFNc and
Ai, moderate levels of IL10 and infected macrophages, as well as
an orientation towards the cellular response. We previously
explained the high increase of Ai and the moderate increase of
MI (see Innate response above). Being produced by MI , IL10 also
increases, but less than Ai (lower production rate). As MI
increases, the activation of the immune response also increases.
In particular, the natural killers increase. They synthesise IFNc,
which promotes the cellular response, whose effectors synthesise
IFNc, resulting in the orientation towards the cellular response.
IL10 does not increase enough to prevent this orientation. As Ai,
the cellular response and IFNc inhibit the infection, but not
enough to compensate the high excretion and infection rates.
The high influence of the excretion rate on the infection
duration is consistent with the results of the sensitivity analysis.
The scenarios explored could correspond to real conditions.
Indeed, an experimental study showed that pig genotypes can
influence the alveolar macrophage abilityto suppress the viral
replication [67]. Moreover, virulent strains vary in their ability to
induce the synthesis of antiviral [16] and IL10 [37] cytokines. So
scenarios S0?S2 could correspond to a pig that is not able to
inhibit the viral replication and that is infected by a highly virulent
type 2 PRRSv field strain, inducing a strong antiviral response and
a moderate IL10 production.
Neutralising antibodies play a key role in the immunological
control of a wide variety of viral infections [16,33]. Consequently,
a strong humoral response, should result in a short infection
duration. PRRSv infections induce high levels of IL10 compared to
the other cytokines and the humoral response levels are similar to
the levels encountered in other viral infection. However, the levels
of neutralising antibodies remain low. The combination of high
levels of IL10 and a strong but inefficient humoral response is often
proposed to explain the long infection duration [11]. Indeed, IL10
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is a major regulator of the immune response and its inhibitory
effects on numerous immune functions could explain several
immunological phenomena observed in PRRSv infection
[33,34,37]. However, the variability in host susceptibility and
viral virulence challenges this hypothesis. PRRSv infections by
virulent or attenuated strains showed no correlation between the
IL10 levels and the infection duration [16]. In a variety of studies,
PRRSv infection resolution was observed without the development
of neutralising antibodies [16]. We found that a dominant
humoral response and high percentages of IL10 can be associated
with either long or short infection durations. Scenarios SB?SA
are consistent with the usual assumption of the ineffective humoral
response. However, scenarios S1?S0 associated short infection
durations with a dominant humoral response. This result is due to
the low excretion and macrophage infection rates, despite the low
levels of innate and adaptive antiviral cytokines.
Concerning TGFb and the regulatory response, few studies
explored their influences on the immune dynamics and the
subsequent infection resolution. The induction of regulatory T
lymphocytes (Treg) during the early stages of infection is considered
as one of the mechanisms that establish chronic or persistent viral
infections [16,33]. According to this hypothesis, our results showed
that a strong regulatory response was associated with very high
levels of IL10 and that it resulted in a prolonged infection
(scenarios S0?SA). Further experimentation considering the Treg
cells and TGFb cytokines are needed to validate our model results.
Conclusion
We built an original and integrative model of the immune
response in the lung to a pathogen targeting pulmonary
macrophages, applied here to PRRSv. This model provides an
interesting framework to explore the macrophage–pathogen
interactions while representing the adaptive response. We used
the model to explore the influence of macrophage permissiveness
and cytokine synthesis capacities on the infection duration and
immune dynamics. A recent review suggests that the concepts
proposed to explain prolonged PRRSv infection have not been
experimentally proved; in particular, the roles of the cytokines and
the orientation of the adaptive response need to be more clearly
elucidated [16]. Our integrative model allowed to simulate
contrasted dynamics in terms of immune response and infection
duration, suggesting hypotheses to explain the apparent contra-
dictions between published results.
In addition, we extracted some synthetic and original elements
from our work.
1. Among the immune variables that can be easily measured,
some were found to characterise immune mechanisms: (a) the
proportions of IL10 and IFNc were good indicators of the
adaptive response orientation; and (b) the level of IL10 was a
good indicator of the level of infected macrophages.
2. Whatever the strain virulence and host susceptibility, the
infection duration was linked to some immune variables: (a) the
level of pro-inflammatory cytokines was a good indicator of the
infection duration; and (b) a dominant regulatory response was
associated with a prolonged infection.
However, to identify and understand the immune mechanisms
responsible for the infection duration, the entire immune response
had to be considered. At least (i) the levels of innate antiviral
cytokines, (ii) the level of IL10, and (iii) the relative levels of IL10
and IFNc were needed.
We found that the macrophage permissiveness and the cytokine
synthesis capacities both influence the infection duration through
various immune mechanisms. Promoting antiviral cytokines or
limiting the macrophage permissiveness and viral replication in
order to reduce the infection duration has only been suggested
[33,34,57]. Classically, two main approaches are associated to
limit the infection: (i) appropriate housing conditions to reduce the
pig susceptibility and (ii) vaccination to improve the immune
response efficiency. Moreover, it has been shown that pig
genotypes can influence the alveolar macrophage ability to
suppress viral replication [51]. Our results suggest that the viral
replication rate is highly influential on the infection duration. So
selecting resistant pigs should be efficient to prevent severe
infections. Concerning the vaccination strategies, vaccines capable
of promoting the synthesis of antiviral cytokines or minimising
IL10 production have been considered in the literature and
numerous experimentation have been carried out, but the current
results are not convincing (reviewed in [16,37]). Obviously,
vaccination strategies need more insight. Our integrative model
provides a powerful framework to go beyond experimental
constraints. In particular, such an approach could be used to
help designing efficient vaccination strategies.
Supporting Information
Figure S1 Preliminary sensitivity analysis: comparison
of the phagocytosis and infection activities. This figure
results from the 243 simulations performed for the preliminary
sensitivity analysis. A: Percentage of phagocyting macrophages
among all macrophages over time (maximum 14%). B: Percentage
of infected macrophages over time (maximum 100%). C:
Phagocytosis activity as a percentage of the phagocytosis and
infection flows, i.e. the ratio between the concentration of
susceptible macrophages becoming phagocyting macrophages
per unit of time and the concentration of susceptible macrophages
becoming phagocyting or latent infected macrophages per unit of
time| 100. At a given time, if a simulation is above the 50% red
line, its phagocytosis flow is higher than its infection flow. These
figures show that, even if there are few phagocyting macrophages
at all times, the phagocytosis activity can be dominant over the
infection activity at given times for susceptible macrophages.
(TIFF)
Figure S2 Parameter space exploration: viral titer. This
figure results from the 6561 simulations performed for the
sensitivity analysis. A: Viral titer over time (red curve: reference
scenario S0). B: Distribution of the viral titer at day 200. Some
simulations resulted in infection persistence, others in infection
resolution occurring at various dates. The viral titer at day 200 was
heterogeneously distributed: 56% of the simulations had a viral
titer lower than 2log10(TCID50=ml), which is usually considered
as the infection resolution; the remaining simulations had viral
titers ranging between 2 and 8:96log10(TCID50=ml). More
precisely: (i) 3.7% of the simulations had a viral titer higher than
the maximal initial inoculation titer (7log10(TCID50=ml)) and (ii)
90% of the simulations had a viral titer lower than its
corresponding inoculation titer (4, 5 or 7log10(TCID50=ml)). In
the lung, PRRSv infection lasts 56 days on average [12] and can
be longer than 200 days [16,41].
(TIFF)
Figure S3 Parameter space exploration: cumulative
number of phagocyting macrophages. This figure results
from the 6561 simulations performed for the sensitivity analysis. A:
Cumulative number of phagocyting macrophages (cMP) over time
Immune Response Modelling to Assess Infection Duration
PLOS ONE | www.plosone.org 16 September 2014 | Volume 9 | Issue 9 | e107818
(red curve: reference scenario S0). B: Distribution of cMP at day 1.
C: Distribution of cMP at day 200. cMP was highly variable
between simulations: between 0.5 and 106:7 macrophages/ml on
the first day, and between 1.4 and 108:4 macrophages/ml at day
200. Most simulations rapidly increased during the first days and
then tended to a threshold. This means that the phagocytosis
activity was maximal at the beginning of the infection, which is
consistent with the literature. Simulations that did not saturate
corresponded to persistent infection. To our knowledge, there are
no experimental studies that measure the concentration of
phagocyting macrophages during a PRRSv infection.
(TIFF)
Figure S4 Parameter space exploration: percentage of
infected macrophages. This figure results from the 6561
simulations performed for the sensitivity analysis. A: Percentage of
infected macrophages among all macrophages (%MI ) over time
(red curve: reference scenario S0). B: Distribution of the %MI
peak value. C: Distribution of the %MI peak date. The peak is
defined as the maximum value of %MI over the course of
infection. The %MI dynamics was highly variable among
simulations but tended to decrease after the first weeks of
infection. At day 200, %MI was higher than 60% for only 4%
of the simulations and lower than 1% for 84% of the simulations.
55% of the simulations peaked during the first week. For 80% of
the simulations, the %MI peak was lower than 20%. Some
experimental studies showed a peak of infected macrophages of
around 40% during the first week of a PRRSv infection [39].
During the first week, only 5% of the simulations had %MI
peaking between 20 and 60%, which is consistent with the
experimental results.
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